Clinical Trial Update: Apatinib for Advanced Non-squamous Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating apatinib for advanced non-squamous head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Head and Neck Neoplasms | Phase 2 | Status: UNKNOWN